Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance
### What you need to know Type 2 diabetes mellitus (T2DM) in children and young people (aged under 18 years) is a more aggressive disease than in older adults and is associated with higher risk of severe long term and potentially life threatening complications (eg, cardiovascular disease, renal disease) compared with other types of diabetes. The worldwide prevalence and annual incidence of T2DM in children and young people is increasing,1 and the National Paediatric Diabetes Audit (NPDA) of England and Wales from 2019-20 showed a prevalence and incidence of 4.5 and 1.7 per 100 000 people 15 ...